ATR signaling cooperates with ATM in the mechanism of low dose hypersensitivity induced by carbon ion beam

DNA Repair

Volumn 34, Issue , 2015, Pages 1-8

  Xue, Lian ^a   Furusawa, Yoshiya ^b   Yu, Dong ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

ATR; Early G2 M checkpoint; High LET; Ionizing radiation; Low dose hyper radiosensitivity

Indexed keywords

ATM PROTEIN; ATR PROTEIN; CARBON; HEAVY ION; HISTONE H3; ATM PROTEIN, HUMAN; ATR PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; LINEAR ENERGY TRANSFER; M PHASE CELL CYCLE CHECKPOINT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIOSENSITIVITY; SIGNAL TRANSDUCTION; CELL CULTURE; CELL LINE; DEFICIENCY; METABOLISM; RADIATION DOSE; RADIATION RESPONSE;

ATAXIA TELANGIECTASIA MUTATED PROTEINS; CARBON; CELL LINE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, RADIATION; G2 PHASE CELL CYCLE CHECKPOINTS; HEAVY IONS; HUMANS; LINEAR ENERGY TRANSFER; RADIATION TOLERANCE; SIGNAL TRANSDUCTION;

EID: 84938268621     PISSN: 15687864     EISSN: 15687856     Source Type: Journal    
DOI: 10.1016/j.dnarep.2015.07.001     Document Type: Article

References (47)

1. Marples B., Joiner M.C. The response of Chinese hamster V79 cells to low radiation doses: evidence of enhanced sensitivity of the whole cell population. Radiat. Res. 1993, 133:41-51.
2. Vaganay-Juery S., Muller C., Marangoni E., et al. Decreased DNA-PK activity in human cancer cells exhibiting hypersensitivity to low-dose irradiation. Br. J. Cancer 2000, 83:514-518.
3. Krueger S.A., Wilson G.D., Piasentin E., et al. The effects of G2-phase enrichment and checkpoint abrogation on low-dose hyper-radiosensitivity. Int. J. Radiat. Oncol. Biol. Phys. 2010, 77:1509-1517.
4. Krueger S.A., Joiner M.C., Weinfeld M., et al. Role of apoptosis in low-dose hyper-radiosensitivity. Radiat. Res. 2007, 167:260-267.
5. Krueger S.A., Collis S.J., Joiner M.C., et al. Transition in survival from low-dose hyper-radiosensitivity to increased radioresistance is independent of activation of ATM Ser1981 activity. Int. J. Radiat. Oncol. Biol. Phys. 2007, 69:1262-1271.
6. Marples B., Collis S.J. Low-dose hyper-radiosensitivity: past, present, and future. Int. J. Radiat. Oncol. Biol. Phys. 2008, 70:1310-1318.
7. Thomas C., Charrier J., Massart C., et al. Low-dose hyper-radiosensitivity of progressive and regressive cells isolated from a rat colon tumour: impact of DNA repair. Int. J. Radiat. Biol. 2008, 84:533-548.
8. Marples B., Wouters B.G., Joiner M.C. An association between the radiation-induced arrest of G2-phase cells and low-dose hyper-radiosensitivity: a plausible underlying mechanism?. Radiat. Res. 2003, 160:38-45.
9. Marples B., Wouters B.G., Collis S.J., et al. Low-dose hyper-radiosensitivity: a consequence of ineffective cell cycle arrest of radiation-damaged G2-phase cells. Radiat. Res. 2004, 161:247-255.
10. Marples B., Cann N.E., Mitchell C.R., et al. Evidence for the involvement of DNA-dependent protein kinase in the phenomena of low dose hyper-radiosensitivity and increased radioresistance. Int. J. Radiat. Biol. 2002, 78:1139-1147.
11. Xu B., Kim S.T., Lim D.S., et al. Two molecularly distinct G(2)/M checkpoints are induced by ionizing irradiation. Mol. Cell. Biol. 2002, 22:1049-1059.
12. Fernet M., Megnin-Chanet F., Hall J., et al. Control of the G2/M checkpoints after exposure to low doses of ionising radiation: implications for hyper-radiosensitivity. DNA Repair (Amst.) 2010, 9:48-57.
13. Hamada N., Imaoka T., Masunaga S., et al. Recent advances in the biology of heavy-ion cancer therapy. J. Radiat. Res. 2010, 51:365-383.
14. Tsoulou E., Baggio L., Cherubini R., et al. Low-dose hypersensitivity of V79 cells under exposure to gamma-rays and 4He ions of different energies: survival and chromosome aberrations. Int. J. Radiat. Biol. 2001, 77:1133-1139.
15. Tsoulou E., Baggio L., Cherubini R., et al. Radiosensitivity of V79 cells after alpha particle radiation at low doses. Radiat. Prot. Dosimetry 2002, 99:237-240.
16. Xue L., Yu D., Furusawa Y., et al. ATM-dependent hyper-radiosensitivity in mammalian cells irradiated by heavy ions. Int. J. Radiat. Oncol. Biol. Phys. 2009, 75:235-243.
17. Xue L., Yu D., Furusawa Y., et al. Regulation of ATM in DNA double strand break repair accounts for the radiosensitivity in human cells exposed to high linear energy transfer ionizing radiation. Mutat. Res. 2009, 670:15-23.
18. Bower J.J., Zhou Y., Zhou T., et al. Revised genetic requirements for the decatenation G2 checkpoint: the role of ATM. Cell Cycle 2010, 9:1617-1628.
19. Yajima H., Fujisawa H., Nakajima N.I., et al. The complexity of DNA double strand breaks is a critical factor enhancing end-resection. DNA Repair (Amst.) 2013, 12:936-946.
20. Fu J., Bian M., Jiang Q., et al. Roles of Aurora kinases in mitosis and tumorigenesis. Mol. Cancer Res. 2007, 5:1-10.
21. Marumoto T., Hirota T., Morisaki T., et al. Roles of aurora-A kinase in mitotic entry and G2 checkpoint in mammalian cells. Genes Cells 2002, 7:1173-1182.
22. Murnion M.E., Adams R.R., Callister D.M., et al. Chromatin-associated protein phosphatase 1 regulates aurora-B and histone H3 phosphorylation. J. Biol. Chem. 2001, 276:26656-26665.
23. Crosio C., Fimia G.M., Loury R., et al. Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian Aurora kinases. Mol. Cell. Biol. 2002, 22:874-885.
24. Tao Y., Leteur C., Calderaro J., et al. The aurora B kinase inhibitor AZD1152 sensitizes cancer cells to fractionated irradiation and induces mitotic catastrophe. Cell Cycle 2009, 8:3172-3181.
25. Yang J., Ikezoe T., Nishioka C., et al. AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo. Blood 2007, 110:2034-2040.
26. Xue L., Furusawa Y., Okayasu R., et al. The complexity of DNA double strand break is a crucial factor for activating ATR signaling pathway for G2/M checkpoint regulation regardless of ATM function. DNA Repair (Amst.) 2015, 25:72-83.
27. Leung-Pineda V., Ryan C.E., Piwnica-Worms H. Phosphorylation of Chk1 by ATR is antagonized by a Chk1-regulated protein phosphatase 2A circuit. Mol. Cell. Biol. 2006, 26:7529-7538.
28. Furnari B., Rhind N., Russell P. Cdc25 mitotic inducer targeted by chk1 DNA damage checkpoint kinase. Science 1997, 277:1495-1497.
29. Sanchez Y., Wong C., Thoma R.S., et al. Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science 1997, 277:1497-1501.
30. Bohrnsen G., Weber K.J., Scholz M. Low dose hypersensitivity and induced resistance of V79 cells after charged particle irradiation using 100MeV/u carbon ions. Radiat. Prot. Dosimetry 2002, 99:255-256.
31. Heuskin A.C., Wera A.C., Riquier H., et al. Low-dose hypersensitivity and bystander effect are not mutually exclusive in A549 lung carcinoma cells after irradiation with charged particles. Radiat. Res. 2013, 180:491-498.
32. Wera A.C., Heuskin A.C., Riquier H., et al. Low-LET proton irradiation of A549 non-small cell lung adenocarcinoma cells: dose response and RBE determination. Radiat. Res. 2013, 179:273-281.
33. Zhao Y., Cui Y., Han J., et al. Cell division cycle 25 homolog c effects on low-dose hyper-radiosensitivity and induced radioresistance at elevated dosage in A549 cells. J. Radiat. Res. 2012, 53:686-694.
34. Deckbar D., Birraux J., Krempler A., et al. Chromosome breakage after G2 checkpoint release. J. Cell Biol. 2007, 176:749-755.
35. Deckbar D., Jeggo P.A., Lobrich M. Understanding the limitations of radiation-induced cell cycle checkpoints. Crit. Rev. Biochem. Mol. Biol. 2011, 46:271-283.
36. Brown E.J., Baltimore D. Essential and dispensable roles of ATR in cell cycle arrest and genome maintenance. Genes Dev. 2003, 17:615-628.
37. Tomimatsu N., Mukherjee B., Burma S. Distinct roles of ATR and DNA-PKcs in triggering DNA damage responses in ATM-deficient cells. EMBO Rep. 2009, 10:629-635.
38. Gupta A., Hunt C.R., Chakraborty S., et al. Role of 53BP1 in the regulation of DNA double-strand break repair pathway choice. Radiat. Res. 2013, 181:1-8.
39. Fattah F., Lee E.H., Weisensel N., et al. Ku regulates the non-homologous end joining pathway choice of DNA double-strand break repair in human somatic cells. PLoS Genet. 2010, 6:e1000855.
40. Shibata A., Moiani D., Arvai A.S., et al. DNA double-strand break repair pathway choice is directed by distinct MRE11 nuclease activities. Mol. Cell 2014, 53:7-18.
41. Grabarz A., Guirouilh-Barbat J., Barascu A., et al. A role for BLM in double-strand break repair pathway choice: prevention of CtIP/Mre11-mediated alternative nonhomologous end-joining. Cell Rep. 2013, 5:21-28.
42. Shibata A., Conrad S., Birraux J., et al. Factors determining DNA double-strand break repair pathway choice in G2 phase. EMBO J. 2011, 30:1079-1092.
43. Okayasu R., Okada M., Okabe A., et al. Repair of DNA damage induced by accelerated heavy ions in mammalian cells proficient and deficient in the non-homologous end-joining pathway. Radiat. Res. 2006, 165:59-67.
44. Wang H., Wang X., Zhang P., et al. The Ku-dependent non-homologous end-joining but not other repair pathway is inhibited by high linear energy transfer ionizing radiation. DNA Repair (Amst.) 2008, 7:725-733.
45. Shang Z.F., Huang B., Xu Q.Z., et al. Inactivation of DNA-dependent protein kinase leads to spindle disruption and mitotic catastrophe with attenuated checkpoint protein 2 phosphorylation in response to DNA damage. Cancer Res. 2010, 70:3657-3666.
46. Lee K.J., Lin Y.F., Chou H.Y., et al. Involvement of DNA-dependent protein kinase in normal cell cycle progression through mitosis. J. Biol. Chem. 2011, 286:12796-12802.
47. Heuskin A.C., Michiels C., Lucas S. Low dose hypersensitivity following in vitro cell irradiation with charged particles: is the mechanism the same as with X-ray radiation. Int. J. Radiat. Biol. 2014, 90:81-89.